A phase I trial of cyclosporine for hospitalized patients with COVID-19
Clinical Trial
[키워드] administration
adverse events
antiviral property
application
Care
center
characterized
chemokine
chemokines
clinical response
conducted
Course
COVID-19
CsA
CXCL10
cyclosporine A
cytokine production
Cytokine storm
Cytokines
discharged
disease
dose
drug
evaluated
exacerbated
feasible
gene expression signature
gene-expression
Health
health emergency
healthcare
Hospitalized
hospitalized patient
hyperinflammation
ill patient
immune dysregulation
inhibitor
intensive care
modulate
New
oxygen
participant
Patient
patients with COVID-19
peripheral blood cell
Phase I
reduction in
reductions in
Registered
required
resource
Safe
serum cytokine
transaminitis
transcriptional profile
treated
Treatment
Trial
Type I IFN
Vaccine
with COVID-19
[DOI] 10.1172/jci.insight.155682 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1172/jci.insight.155682 PMC 바로가기 [Article Type] Clinical Trial